copycat glp-1
Spot Glp-1 / Weight-Loss Drugs Savings Today
Copycat GLP-1 drugs can lower annual spend by more than 90 percent while delivering similar weight-loss results when dosed correctly, though they carry safety and insurance hurdles. In 2026, more than 1,700 adverse event reports involving compounded semaglutide and tirzepatide have been logged by the FDA, underscoring the need